Galderma

Galderma (formerly Nestle Skin Health), owned by EQT Partners AB is focused on science-based solutions for skin health. Galderma SA, owned by EQT Partners AB develops dermatology products. The Company manufactures drugs, medical solutions, and therapeutic skin care products to treat acne, rosacea, psoriasis, skin cancer, and nail diseases.In December 2022, Galderma SA opened its U.S. headquarters in downtown Dallas.In February 2022, Taro Pharmaceutical Industries Ltd announced it signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC), from Galderma.In January 2022, Galderma SA has received antitrust clearance from the U.S. authorities and completely acquired ALASTIN Skincare Inc.In November 2021, Galderma announced that signed a definitive agreement to acquire ALASTIN Skincare, Inc.In April 2015, Galderma planned to enter into the nutraceutical market through the acquisition of certain assets of Inneov Group. In June 2015, Galderma completed the acquisition.In February 2014, Nestle planned to acquire L'Oréal's 50% stake in